Cyclin-Dependent Kinase Inhibitor p21 WAF1/CIP1 Facilitates the Development of Cardiac Hypertrophy
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Cyclin-Dependent Kinase Inhibitor p21 WAF1/CIP1 Facilitates the Development of Cardiac Hypertrophy ; volume:42 ; number:4 ; year:2017 ; pages:1645-1656 ; extent:12
Cellular physiology and biochemistry ; 42, Heft 4 (2017), 1645-1656 (gesamt 12)
- Creator
-
Tong, Yang-Fei
Wang, Yan
Ding, Yuan-Yuan
Li, Jing-Mei
Pan, Xi-Chun
Lu, Xiao-Lan
Chen, Xiao-Hong
Liu, Ya
Zhang, Hai-Gang
- DOI
-
10.1159/000479407
- URN
-
urn:nbn:de:101:1-2404250044163.461204050042
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:00 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tong, Yang-Fei
- Wang, Yan
- Ding, Yuan-Yuan
- Li, Jing-Mei
- Pan, Xi-Chun
- Lu, Xiao-Lan
- Chen, Xiao-Hong
- Liu, Ya
- Zhang, Hai-Gang
Other Objects (12)
Cyclin-dependent kinases
Cyclin-dependent kinases and rare developmental disorders
The expression of cyclin-dependent kinase inhibitors p15, p16, p21, and p27 during ovarian follicle growth initiation in the mouse
Cyclin-dependent kinases and CDK inhibitors in virus-associated cancers
Activation of cyclin-dependent kinase 5 mediates orofacial mechanical hyperalgesia
Cyclin-dependent kinase 5 mediates pleiotrophin-induced endothelial cell migration
TRAILblazing: cyclin-dependent kinase 9 (CDK9) as target in pancreatic cancer
Mitotic p21Cip1/CDKN1A is regulated by cyclin-dependent kinase 1 phosphorylation
Proteomic profiling reveals that ESR1 mutations enhance cyclin-dependent kinase signaling
Biochemical characterization of the human Cyclin-dependent kinases Cdk7 and Cdk10
Cancer therapy by cyclin-dependent kinase inhibitors (CDKIs) : bench to bedside
A cyclin-dependent kinase-mediated phosphorylation switch of disordered protein condensation
Cyclin-dependent kinases
Cyclin-dependent kinases and rare developmental disorders
The expression of cyclin-dependent kinase inhibitors p15, p16, p21, and p27 during ovarian follicle growth initiation in the mouse
Cyclin-dependent kinases and CDK inhibitors in virus-associated cancers
Activation of cyclin-dependent kinase 5 mediates orofacial mechanical hyperalgesia
Cyclin-dependent kinase 5 mediates pleiotrophin-induced endothelial cell migration
TRAILblazing: cyclin-dependent kinase 9 (CDK9) as target in pancreatic cancer
Mitotic p21Cip1/CDKN1A is regulated by cyclin-dependent kinase 1 phosphorylation
Proteomic profiling reveals that ESR1 mutations enhance cyclin-dependent kinase signaling
Biochemical characterization of the human Cyclin-dependent kinases Cdk7 and Cdk10
Cancer therapy by cyclin-dependent kinase inhibitors (CDKIs) : bench to bedside
A cyclin-dependent kinase-mediated phosphorylation switch of disordered protein condensation
Cyclin-dependent kinases
Cyclin-dependent kinases and rare developmental disorders
The expression of cyclin-dependent kinase inhibitors p15, p16, p21, and p27 during ovarian follicle growth initiation in the mouse
Cyclin-dependent kinases and CDK inhibitors in virus-associated cancers
Activation of cyclin-dependent kinase 5 mediates orofacial mechanical hyperalgesia
Cyclin-dependent kinase 5 mediates pleiotrophin-induced endothelial cell migration
TRAILblazing: cyclin-dependent kinase 9 (CDK9) as target in pancreatic cancer
Mitotic p21Cip1/CDKN1A is regulated by cyclin-dependent kinase 1 phosphorylation
Proteomic profiling reveals that ESR1 mutations enhance cyclin-dependent kinase signaling
Biochemical characterization of the human Cyclin-dependent kinases Cdk7 and Cdk10
Cancer therapy by cyclin-dependent kinase inhibitors (CDKIs) : bench to bedside